Brown

Corey Brown

Partner
Co-Chair, Mergers & Acquisitions Practice Group
Boston

I work hard to ensure my clients achieve their goals and strategic objectives, even on the most complex of deals.

Corey Brown is a co-chair of the firm's Mergers & Acquisitions Practice Group. Recognized nationally as a “Next Generation Lawyer” in middle market M&A by The Legal 500, his practice focuses on representing private equity funds and strategics in buy-side and sell-side transactions, including leveraged buyouts, minority and growth investments, going-private transactions, carve-out acquisitions, tender offers, and other strategic business transactions.
 

Corey’s practice spans many different industries, with a particular focus in technology and life sciences, and includes buyers and sellers of both public and private companies, including private equity sponsors. Corey also has extensive experience in cross-border transactions, having advised on transactions involving parties in North America, Europe, Asia and South America. He routinely counsels boards and executive officers on their significant transactions, including fiduciary duty issues, and general corporate matters. Corey also regularly works with portfolio companies of private equity firms on their transactional and general corporate matters. 

He has provided legal counsel to: Thomas H. Lee Partners; Providence Equity Partners; Advent International Corporation; Mill Road Capital; The Gores Group; Dell EMC; Alexion Pharmaceuticals; Thermo Fisher Scientific; the Kraft Group; and many others. Corey previously worked as an intern for The Honorable Thomas Balmer of the Oregon Supreme Court. 

Education

  • Boston College Law School, J.D., magna cum laude, 2011
  • University of Oregon, B.A., 2008

Bar and Court Admissions

BAR ADMISSIONS
  • Massachusetts 

Experience

  • Integrated Prescription Management in connection with its growth investment received from Court Square Capital Partners
  • Winchester Interconnect, a subsidiary of Aptiv PLC (NYSE: APTV), in several transactions, including:
    • its acquisition of El-Com Systems
    • its acquisition of Ulti-Mate Connector
  • Datadog, provider of a SaaS-based monitoring platform for cloud applications in its acquisition of Timber Technologies
  • ConstructSecure, provider of an SaaS platform that leverages leading risk and financial indicators to accurately pre-qualify subcontractors and vendors to improve safety, in a growth equity investment by Summit Partners
  • RealHealthData, a technology company focused on providing unique, real world data insights, in the sale of substantially all of its assets to Amplity
  • Global cannabis operator Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in its $69 million acquisition of Project Cannabis, a leading cannabis cultivator, wholesaler and retailer 
  • Represented New-Indy Containerboard, a joint-venture formed by the Kraft Group and Schwarz Partners, LP, in its acquisition of Shoreline Container
  • Global biopharmaceutical company Alexion Pharmaceuticals (Nasdaq: ALXN) its acquisition of Achillion (Nasdaq: ACHN), a clinical-stage biopharmaceutical company for $1.2 billion. 
  • Global biopharmaceutical company Alexion Pharmaceuticals, Inc. in its acquisition of Syntimmune, Inc. for a potential aggregate purchase price of up to $1.2 billion
  • Mosaic Research Management in the sale of its subsidiary, Stream Media Group, to AlphaSense
  • ROnShape Inc., creators of the first Software as a Service (SaaS) product development platform that unites robust computer aided design (CAD) with powerful data management and collaboration tools, in signing a definitive agreement to sell the business to global technology company PTC Inc. for approximately $470 million.
  • Global biotechnology company Thermo Fisher Scientific Inc. (NYSE: TMO) in its $477 million acquisition of Becton, Dickinson and Company’s Advanced Bioprocessing business
  • Global biopharmaceutical company Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) in a partnership with Complement Pharma to co-develop a pre-clinical C6 complement inhibitor for neurodegenerative disorders
  • Dell EMC in the sale of EMC’s enterprise content division to Open Text Corporation (Nasdaq: OTEX) (TSX: OTC) for $1.62B.
  • Dell Technologies in its $145.8 million sale of Mozy, Inc. to Carbonite, Inc. (Nasdaq: CARB)
  • Good Start Genetics, Inc. in its acquisition by Invitae Corporation (NYSE: NVTA)
  • Dragon Innovation in its sale to Avnet, Inc.
  • Interconnect Systems, Inc., a designer and manufacturer of high density silicon packaging with advanced interconnect technologies, in its acquisition by Molex LLC, a leading global manufacturer of electronic solutions
  • Conservation Services Group, Inc., the leading provider of residential energy efficiency programs in the US, in the sale of substantially all its assets to CLEAResult Consulting, Inc., a leader in providing energy efficiency programs and a portfolio company of General Atlantic LLC
  • Mill Road Capital in its sale of Galaxy Nutritional Foods to Greenspace Brands
  • Acer Therapeutics in its merger with Opexa Therapeutics.
  • Costa Inc. (formerly known as A.T. Cross Company), a Nasdaq-listed designer, manufacturer, and marketer of polarized sunglasses, in its $270 million sale to Essilor International SA, a France-based publicly traded designer, manufacturer, and seller of ophthalmic lenses and ophthalmic optical instruments
  • A.T. Cross Company, a publicly traded designer and marketer of branded personal and business accessories, in the sale of its Cross Accessory Division to a newly formed affiliate of Clarion Capital Partners, LLC
  • Thomas H. Lee Partners and its portfolio companies in numerous transactions, including CompuCom Systems, Inc. and Systems Maintenance Services
  • Guggenheim Partners, LLC in its acquisition of Dick Clark Productions
  • Providence Equity Partners and its portfolio companies in its transactions involving Learfield Communications, Nelligan Sports Marketing, Professional Association of Diving Instructors (PADI), and the approximately $1 billion sale of certain television station assets owned by Newport Television
  • Oaktree Capital Management and its France-based portfolio company Ileos, SA in its joint venture with Visant Corporation
  • Advent International Corporation and its portfolio companies in numerous transactions, including its acquisition of Noosa Yoghurt, LLC and Morrison Supply Company
  • American Capital, Ltd. in its sale of Specialty Brands of America, Inc.

PROFESSIONAL EXPERIENCE
  • Judicial Extern for Hon. Thomas A. Balmer (Chief Justice of the Oregon Supreme Court)

Honors & Involvement

HONORS
  • Recognized nationally as a “Next Generation Lawyer” by The Legal 500 (2020-2022) 
  • Recognized as a "Rising Star" by The Legal 500 (2019)

Speaking Engagements

  • “What Does the Current Ukraine Crisis Mean for Global Private Equity Deals?” American Bar Association - Business Law Section - Spring Meeting (April 2022)